Table 3.
LDL < 100 mg/dL | Clinical action measure† | |
---|---|---|
Age + facility | 0.51 (0.49,0.53) | 0.68 (0.66,0.71) |
Age + facility + number of primary care visits + type of facility‡ | 0.60 (0.58,0.62) | 0.64 (0.62,0.66) |
Age + facility + number of primary care visits + type of facility + IHD§ + BMI║ | 0.61 (0.59,0.63) | 0.67 (0.65,0.70) |
LDL low-density lipoprotein, IHD ischemic heart disease, BMI body mass index
*Odds ratios and 95 % confidence intervals †Clinical action measure defined as: LDL < 100 mg/dL; or LDL ≥ 100 mg/dL and the patient was prescribed a moderate or high-dose statin at the time of the test; or index LDL ≥ 100 mg/dL and the patient received other appropriate clinical action within 90 days. Those with no LDL test recorded, but who were prescribed a moderate or high dose statin, also passed the measure on the basis of the prescription. ‡VA medical center or CBOC-community-based outpatient clinic. §IHD-ischemic heart disease. ║BMI – body-mass index (kg/m2)